A government study evaluating real-world use of Pfizer’s Covid-19 vaccine during the Omicron wave found two doses protected against severe disease in children under 17 years but didn’t work quite as well in younger kids
The Covid-19 vaccine from Pfizer Inc.
and partner BioNTech SE was highly effective at reducing the risk of severe disease in children 17 years and younger during theThe two-dose vaccine reduced the risk of Covid-19 hospitalization in children 5 to 11 years by 74% and by 92% or higher in children 12 to 17, according to the study published Tuesday by the Centers for Disease Control and Prevention.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 cases are declining in Texas schools after omicron surgeStudent and staff COVID-19 cases are declining after districts reported the highest levels since the pandemic began. But the data is incomplete and likely an undercount.
Read more »
Vaccine protection against Covid-19 fell substantially for children during Omicron surgeMany vaccinated kids experienced breakthrough infections during the Omicron surge, though protection against hospitalization remained stronger, a large new government-funded study found
Read more »
Covid-19: One more Covid-related death and 1,908 casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,208.
Read more »
Fourth dose of COVID vaccine offers only slight boost against Omicron infectionIsraeli trial shows a fourth vaccination raises antibody levels but provides little extra protection against SARS-CoV-2 infection.
Read more »
COVID Omicron Updates: Demand for free government coronavirus tests plummets along with casesNearly half of the 500 million free COVID-19 tests the Biden administration recently made available to the public still have not been claimed as virus cases plummet and people feel less urgency to test.
Read more »
Pfizer Covid vaccine was just 12% effective against omicron in kids 5 to 11, study findsNY health officials found that the effectiveness of Pfizer's vaccine against Covid plummeted from 68% to 12% for children ages 5 to 11 as the omicron surged.
Read more »